Form 4: PMV Pharmaceuticals Executive Acquires Stock Options
SEC Form 4
Deepika Jalota, Chief Development Officer of PMV Pharmaceuticals, reports the acquisition of stock options and shares.
Summary
- Deepika Jalota, Chief Development Officer of PMV Pharmaceuticals, filed a Form 4.
- The filing reports the acquisition of 300,000 employee stock options with an exercise price of $1.32, vesting monthly starting April 3, 2025, and expiring on March 3, 2035.
- It also reports ownership of 123,024 shares of common stock, including 4,741 shares acquired through the Employee Stock Purchase Plan between May 2021 and November 2022.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock option grants to an executive.
Positives
- The acquisition of stock options by a key executive could signal confidence in the company's future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies.
Stakeholder Impact
- The stock option grant aligns the executive's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| May 20, 2021 | 2,276 shares acquired under the Issuer's Employee Stock Purchase Plan |
| November 19, 2021 | 359 shares acquired under the Issuer's Employee Stock Purchase Plan |
| May 20, 2022 | 993 shares acquired under the Issuer's Employee Stock Purchase Plan |
| November 21, 2022 | 1,113 shares acquired under the Issuer's Employee Stock Purchase Plan |
| March 3, 2025 | Date of the stock option grant and earliest transaction date |
| April 3, 2025 | Vesting start date for the stock options |
| March 3, 2035 | Expiration date for the stock options |
| March 05, 2025 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.